StockWatch
·
Pharmaceuticals
Loan & Debt12 Oct 2026, 12:36 pm

Jubilant Pharmova Approves NCD Issuance Up to ₹800 Crore

AI Summary

Jubilant Pharmova Limited's Board of Directors has approved the issuance of up to 80,000 Secured/Unsecured, Listed, Rated, Redeemable Non-Convertible Debentures (NCDs) with a face value of ₹1,00,000 each, aggregating up to ₹800 crore. The issuance will be on a private placement basis in one or more tranches. Additionally, the company will seek members' authorization via Special Resolution through Postal Ballot for issuing non-convertible debt securities up to ₹2,500 crore outstanding at any time within one year. The NCDs are proposed to be listed on the BSE, with tenure up to five years and coupon/interest to be discovered during bidding.

Key Highlights

  • Board approved issuance of NCDs worth up to ₹800 crore.
  • NCDs will be issued on a private placement basis.
  • Members' approval sought for debt securities up to ₹2,500 crore.
  • NCDs will be listed on the Bombay Stock Exchange (BSE).
  • Coupon/interest to be determined via bidding process.